| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Ciprofloxacin | FAERS: 10 | US FAERS | |
| 2 | Finasteride | FAERS: 7 | US FAERS | |
| 3 | Teriparatide | FAERS: 4 | US FAERS | |
| 4 | Thyroxine | FAERS: 4 | US FAERS | |
| 5 | Norgestrel | FAERS: 3 | US FAERS | |
| 6 | Octreotide | FAERS: 3 | US FAERS | |
| 7 | Nexium 24hr | FAERS: 2 | US FAERS | |
| 8 | Nifedipine | FAERS: 2 | US FAERS | |
| 9 | Pregabalin | FAERS: 2 | US FAERS | |
| 10 | Sertraline | FAERS: 2 | US FAERS | |
| 11 | Sunitinib | FAERS: 2 | US FAERS | |
| 12 | Valproic Acid | FAERS: 2 | US FAERS | |
| 13 | Carbamazepine | FAERS: 1 | US FAERS | |
| 14 | Celecoxib | FAERS: 1 | US FAERS | |
| 15 | Cetirizine | FAERS: 1 | US FAERS | |
| 16 | Diovan Hct | FAERS: 1 | US FAERS | |
| 17 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 18 | Esomeprazole | FAERS: 1 | US FAERS | |
| 19 | Fluticasone | FAERS: 1 | US FAERS | |
| 20 | Gabapentin | FAERS: 1 | US FAERS | |
| 21 | Itraconazole | FAERS: 1 | OFFSIDES US FAERS | |
| 22 | Lamotrigine | FAERS: 1 | US FAERS | |
| 23 | Letrozole | FAERS: 1 | US FAERS | |
| 24 | Methimazole | FAERS: 1 | US FAERS | |
| 25 | Omeprazole | FAERS: 1 | US FAERS | |
| 26 | Pemetrexed | FAERS: 1 | US FAERS | |
| 27 | Prednisone | FAERS: 1 | US FAERS | |
| 28 | Temozolomide | FAERS: 1 | US FAERS | |
| 29 | Topiramate | FAERS: 1 | US FAERS | |
| 30 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 31 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 32 | eslicarbazepine acetate | FAERS: 1 | US FAERS | |
| 33 | lanreotide | FAERS: 1 | US FAERS | |
| 34 | patiromer | FAERS: 1 | US FAERS | |
| 35 | tofacitinib | FAERS: 1 | US FAERS | |
| 36 | Carvedilol | OFFSIDES | ||
| 37 | Hydrocortisone | OFFSIDES | ||
| 38 | trandolapril | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.